@ZeroCandida

Bringing women’s healthcare into the 21st century 🌸 $ZCT.V #ZCTFF

 Toronto, Ontario
zero-candida.com
Joined November 2024
  • Tweets43
  • Following52
  • Followers55
7Media
Zero Candida Technologies retweeted
Virtual Investor Conferences@RIConferences7 Aug 2025
Join the OTCQB Venture Virtual Investor Conference at 10am ET today. Presentations by: @SurgeCopper @Silver47co @natures63491 @ZeroCandida @nxtgn_digital @TeloGenomics @zomedica @wasteenergycorp @CleangoInno @sekurprivate @cybercatch_ Register: bit.ly/3GLfBSH
2
7
10
606
Zero Candida Technologies retweeted
Pharm. Greatman
@OGreat64 Apr 2025
VAGINAL CANDIDIASIS You cannot skip the candida conversation when discussing infections that affect ladies. This thread explains all you need to know about vaginal candidiasis (yeast infection) and how to keep it under control! A thread
13
215
776
179,540
Zero Candida Technologies retweeted
Cision/PR Newswire Israel@PRNewswireIL2 Apr 2025
#Zero #Candida #Technologies #Reports #Full #Year 2024 #Financial #Results and #Business #Highlights tinyurl.com/bdcvdfd4 $ZCT @ZeroCandida
1
1
1
79
Zero Candida Technologies retweeted
Proactive
@proactive_x24 Mar 2025
Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions @ZeroCandida #TSXV #OTCQB #ZCT #ZCTFF ow.ly/t3KF1063mFG

Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions

Markets and small-cap news.

themarketreporter.co.uk
1
535
Zero Candida Technologies retweeted
Cision/PR Newswire Israel@PRNewswireIL12 Mar 2025
#Zero #Candida #Commences #Trading on #OTCQB #Market tinyurl.com/bd8rjac4 $ZCT @ZeroCandida
1
1
145
Zero Candida Technologies retweeted
INN Life Science
@INN_LifeScience3 Mar 2025
With 75% of women experiencing vulvovaginal candidiasis, the market potential is immense. The antifungal drugs market is valued at $15.8B and projected to grow. Don't miss out on this transformative opportunity! investingnews.com/revolution… #WomensHealth #Investing @ZeroCandida #ZCT $ZCT

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The...

investingnews.com
1
1
64
Zero Candida Technologies retweeted
InvestorIdeas.com
@InvestorIdeas14 Feb 2025
Investor Ideas New #StockstoWatch in #LifeSciences and #AI February 14, 2025 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors. 📷 The newest life sciences companies are involved in woman's health, microbiology testing, cannabinoid pharmaceuticals and drug development using AI. The latest AI companies are involved in autonomous robotics, AI/sensor technology and marketing and business solutions. New stocks added today: Zero Candida Technologies Inc. (TSXV:ZCT), Innovotech, Inc. (TSXV: $IOT.V), SciSparc Ltd. (Nasdaq: $SPRC), Bioxytran, Inc. (OTCQB: $BIXT) Nauticus Robotics, Inc. (NASDAQ: $KITT), Realbotix Corp. (TSX-V: $BOT;.V OTC: $XBOTF), Wytec International, Inc. (OTCQB: $WYTC), Onar, Inc. (OTCQB: $RELT). investorideas.com/news/2025/…

Investorideas.com: Investing Ideas, Stock News & Podcasts 2025

Explore the best investing ideas for 2025 at Investorideas.com. Get stock news, podcasts, videos, and insights on AI, crypto, cannabis, cleantech, mining, gaming, and more.

investorideas.com
1
1
78
Zero Candida Technologies retweeted
Proactive USA@proactive_NA11 Feb 2025
Vulvovaginal candidiasis market poised for $2B growth by 2030 @ZeroCandida #TSXV #ZCT ow.ly/1yBs105Zk3u

Vulvovaginal candidiasis market poised for $2B growth by 2030

The global vulvovaginal candidiasis (VVC) market is growing rapidly due to the increasing prevalence and awareness of the condition. VVC, commonly referred...

proactiveinvestors.com
1
1
72
Zero Candida Technologies retweeted
Proactive USA@proactive_NA11 Feb 2025
Market growth spurs innovation in vulvovaginal candidiasis therapies @ZeroCandida #TSXV #ZCT ow.ly/ytGH105Zk3l

Vulvovaginal candidiasis market poised for $2B growth by 2030

The global vulvovaginal candidiasis (VVC) market is growing rapidly due to the increasing prevalence and awareness of the condition. VVC, commonly referred...

proactiveinvestors.com
1
1
82
Zero Candida Technologies retweeted
INN Life Science
@INN_LifeScience7 Feb 2025
Exciting advancements in antifungal treatments are revolutionizing women's health! With 75% of women affected by VVC, the market is ripe for innovation. Discover how new therapies and investment opportunities are shaping the future of healthcare! #WomensHealth #Investing @ZeroCandida $ZCT #ZCT investingnews.com/revolution…

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The...

investingnews.com
1
1
73
Zero Candida Technologies retweeted
Proactive USA@proactive_NA3 Feb 2025
Zero Candida market could reach $2B by 2030, Moore Financial says @ZeroCandida #TSXV #ZCT ow.ly/sSul105YATM

Zero Candida market could reach $2B by 2030, Moore Financial says

Zero Candida Ltd (TSX-V:ZCT), an Israeli FemTech medical device company, is tapping into a market that could exceed $2 billion by 2030, according to an...

proactiveinvestors.com
1
2
88
Zero Candida Technologies retweeted
INN Life Science
@INN_LifeScience29 Jan 2025
With 75% of women experiencing vulvovaginal candidiasis, the market potential is immense. The antifungal drugs market is valued at $15.8B and projected to grow. Don't miss out on this transformative opportunity! investingnews.com/revolution… #WomensHealth #Investing @ZeroCandida #ZCT $ZCT

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The...

investingnews.com
1
1
96
Zero Candida Technologies retweeted
Proactive USA@proactive_NA28 Jan 2025
Zero Candida eyes FDA submission following upcoming human trials of AI-powered Candida treatment device @ZeroCandida #TSXV #ZCT ow.ly/IMhv105Y7Jc

Zero Candida prepares AI-powered candida therapy for market debut

Zero Candida Ltd (TSX-V:ZCT), a company pioneering a non-drug treatment for Candida infections, has provided investors with an update on its groundbreaking...

proactiveinvestors.com
1
1
71
Zero Candida Technologies retweeted
Proactive USA@proactive_NA28 Jan 2025
Zero Candida prepares AI-powered candida therapy for market debut @ZeroCandida #TSXV #ZCT ow.ly/gx2A105Y7JQ

Zero Candida prepares AI-powered candida therapy for market debut

Zero Candida Ltd (TSX-V:ZCT), a company pioneering a non-drug treatment for Candida infections, has provided investors with an update on its groundbreaking...

proactiveinvestors.com
1
1
86
Zero Candida Technologies retweeted
INN Life Science
@INN_LifeScience23 Jan 2025
Exciting advancements in antifungal treatments are revolutionizing women's health! With 75% of women affected by VVC, the market is ripe for innovation. Discover how new therapies and investment opportunities are shaping the future of healthcare! #WomensHealth #Investing @ZeroCandida $ZCT #ZCT investingnews.com/revolution…

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities. The...

investingnews.com
1
1
114
Zero Candida Technologies retweeted
Proactive USA@proactive_NA16 Jan 2025
Zero Candida lists on Frankfurt Stock Exchange, discuss upcoming milestones in webinar @ZeroCandida #TSXV #ZCT ow.ly/3HtH105X0xY

Zero Candida lists on Frankfurt Stock Exchange, discuss upcoming milestones in webinar

Zero Candida Ltd (TSX-V:ZCT) announced that its shares are now listed on the Frankfurt Stock Exchange (FSE) under the ticker symbol “9L2.” The company is...

proactiveinvestors.com
1
2
90
Zero Candida Technologies retweeted
Proactive USA@proactive_NA6 Jan 2025
Zero Candida eyes FDA submission for AI-powered yeast infection treatment device @ZeroCandida #TSXV #ZCT ow.ly/heyM105W4ni

Zero Candida eyes FDA submission for AI-powered yeast infection treatment device

Zero Candida Ltd (TSX-V:ZCT) has revealed plans to complete preclinical studies for its ZC-1-A device by the third quarter of 2025, paving the way for FDA...

proactiveinvestors.com
1
1
83
Zero Candida Technologies retweeted
Proactive Canada@proactive_ca21 Dec 2024
$ZCT Zero Candida secures South African patent for AI-powered device – ICYMI tinyurl.com/28p9apr4 #ZCT

Zero Candida secures South African patent for AI-powered device – ICYMI

Zero Candida Ltd (TSX-V:ZCT) is at the forefront of biotech innovation, addressing the growing need for effective solutions to combat fungal infections. In...

proactiveinvestors.com
1
1
93
Zero Candida Technologies retweeted
Proactive USA@proactive_NA21 Dec 2024
Zero Candida secures South African patent for AI-powered device – ICYMI @ZeroCandida #TSXV #ZCT ow.ly/2Fou105SfXi

Zero Candida secures South African patent for AI-powered device – ICYMI

Zero Candida Ltd (TSX-V:ZCT) is at the forefront of biotech innovation, addressing the growing need for effective solutions to combat fungal infections. In...

proactiveinvestors.com
1
1
89
Zero Candida Technologies retweeted
Tech Investing News
@INN_Technology19 Dec 2024
Competition in the #artificialintelligence (#AI) sector escalated dramatically in 2024, with major #tech companies #investing billions in a race to research and develop advanced #AItechnologies. #NASDAQstocks #AIstocks #artificialintelligenceinvesting investingnews.com/ai-market-…

AI Market 2025 Year-End Review

2025 marked the digestion phase for artificial intelligence (AI). Central to this shift was the widespread move from pilot projects to full-scale implementation of AI, even as companies navigated...

investingnews.com
1
1
2
135
Load more